Banner
Late-Breaking Analysis In Hypertension Shows That Antihypertensive Treatments Differ In Their Ability To Preserve Lives

STOCKHOLM, August 30, 2010 /PRNewswire/ -- According to the results of a late-breaking analysis...

Clinical Results For New Treatment Of Bacterial Vaginosis Infection

The Swedish company Laccure AB recently got CE marking as a Class IIa medical device product for...

88 Percent Of UK Doctors Believe Whiplash Claims Are Exaggerated

AXA, a UK car insurer, has surveyed UK doctors as part of its ongoing campaign to understand the...

On Facebook, Women Are More Plentiful But Men Are Better Ad Targets

Global digital marketing companies Resolution Media and Kenshoo Social published a new report today...

User picture.
Anna OhldenRSS Feed of this column.

Media Relations Executive, PR Newswire Europe... Read More »

Blogroll

NEW YORK and LONDON, February 27 /PRNewswire/ --

Panther Express, a leading global provider of content delivery services, today announced the completion of a US$15.75 million Series B round of venture financing led by Index Ventures. Gold Hill Capital and existing investor Greylock Partners also participated. Panther will use the funds for international expansion and further infrastructure investment to support its growing list of customers.

ANDOVER, England, February 27 /PRNewswire/ --

- Farmers, Livestock Keepers, and Veterinarians can now Become Proactive in Responding to Outbreaks of Notifiable Animal Disease Such as Bluetongue, Avian Influenza and Foot and Mouth Disease

Voice and text broadcaster Relay Station today announces that Animal Health, the government's executive agency responsible for ensuring the health and welfare of farmed animals in Great Britain, has selected its broadcasting technology to launch a managed multi-form, early-warning subscription service for farmers, livestock keepers and veterinarians and all others concerned about animal disease.

HAINAN, China, February 27 /PRNewswire/ --

Addintools announced today the launch of Classic Menu for Office 2007 v3.91, an interface add-on for Microsoft Office 2007 that brings back the classic style of the Microsoft Office 2003 interface with all the new features of Microsoft Office 2007, as well as the ability to automatically deploy to the client's computers in enterprises or organizations.

MELBOURNE, Australia, February 27 /PRNewswire/ --

The Walter and Eliza Hall Institute of Medical Research (WEHI) announced today that Abbott, a global, broad-based, healthcare company, Genentech, a leading biotechnology company based in South San Francisco and WEHI have joined in a tripartite research collaboration to discover new anti-cancer drugs.

"This exciting three party research collaboration among world leaders in this field may increase the chance of translating basic scientific research in apoptosis, the process of programmed cell death, as carried out by our collaborators over recent years, into novel targeted cancer therapeutics," says Dr. Julian Clark, Head of Business Development at WEHI.

LONDON, February 27 /PRNewswire/ -- Folic Acid Action (FAA)(1) is challenging concerns raised by the Food Standards Agency (FSA) about the risk of excessive intake of folic acid, amid fears that it may stop women planning a pregnancy from supplementing their diet with this essential nutrient for the unborn child.

FAA is also highlighting how important it is that with or without fortification, women who are trying to conceive must take additional folic acid and says that current advice on this lacks clarity.

ZURICH, Switzerland, February 27 /PRNewswire/ -- Solianis sees its Multi-Sensor Technology as a promising approach to continuous non-invasive glucose monitoring. Professor Marc Donath, member of the Solianis Scientific Advisory Board and Professor for endocrinology and diabetology at the University Hospital in Zurich, Switzerland, has supervised multiple trials during the last years at the hospital. These trials have shown that Solianis' multi-sensor technology operates under various conditions to track glucose changes in the human body. Today, in their daily lives, patients are wearing a first configuration of the device to test its applicability.